PTGS2 and cancer: For the pathological roles it plays and experimental observations, over-expression of COX-2 is associated with inflammation, initiation of cancer, cancer progression, activation of vascular endothelial growth factor, angiogenesis, proliferation of surviving cancer stem cells, invasion, metastasis and tumour relapse after therapy [8–10].